Relationship of metabolic risk factors and development of cardiovascular disease and diabetes

被引:140
作者
Haffner, Steven M. [1 ]
机构
[1] Univ Texas, Hlth Sci Ctr, Dept Med & Clin Epidemiol, San Antonio, TX 78229 USA
关键词
coronary heart disease; diabetes; non-alcoholic fatty liver disease; metabolic syndrome; C-reactive protein;
D O I
10.1038/oby.2006.291
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The prevalence of obesity and diabetes has reached pandemic proportions. Obesity, particularly in association with high waist circumference and high BMI, is an independent risk factor for coronary heart disease (CHD) and diabetes. Several large studies have shown that marginal (5 lb) to moderate (11 to 22 lb) weight gain in adulthood (age 20 to 50 years) increases the risk of chronic disease and negatively affects CHD risk status. The metabolic syndrome, a clustering of cardiovascular and metabolic risk factors that includes abdominal obesity, is increasing among adults and children and is strongly associated with the development of diabetes and CHD. Recent evidence suggests that elevated liver enzymes, an indicator of non-alcoholic fatty liver disease, may comprise an additional component of the metabolic syndrome and may serve as a surrogate marker for type 2 diabetes, particularly if used in conjunction with C-reactive protein.
引用
收藏
页码:121S / 127S
页数:7
相关论文
共 30 条
[1]   NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older [J].
Alexander, CM ;
Landsman, PB ;
Teutsch, SM ;
Haffner, SM .
DIABETES, 2003, 52 (05) :1210-1214
[2]  
[Anonymous], 1999, WHONCDNCS992
[3]  
[Anonymous], 2005, The IDF consensus worldwide definition of the metabolic syndrome
[4]   Body-mass index and mortality in a prospective cohort of US adults [J].
Calle, EE ;
Thun, MJ ;
Petrelli, JM ;
Rodriguez, C ;
Heath, CW .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (15) :1097-1105
[5]   Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) [J].
Cleeman, JI ;
Grundy, SM ;
Becker, D ;
Clark, LT ;
Cooper, RS ;
Denke, MA ;
Howard, WJ ;
Hunninghake, DB ;
Illingworth, DR ;
Luepker, RV ;
McBride, P ;
McKenney, JM ;
Pasternak, RC ;
Stone, NJ ;
Van Horn, L ;
Brewer, HB ;
Ernst, ND ;
Gordon, D ;
Levy, D ;
Rifkind, B ;
Rossouw, JE ;
Savage, P ;
Haffner, SM ;
Orloff, DG ;
Proschan, MA ;
Schwartz, JS ;
Sempos, CT ;
Shero, ST ;
Murray, EZ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19) :2486-2497
[6]   WEIGHT-GAIN AS A RISK FACTOR FOR CLINICAL DIABETES-MELLITUS IN WOMEN [J].
COLDITZ, GA ;
WILLETT, WC ;
ROTNITZKY, A ;
MANSON, JE .
ANNALS OF INTERNAL MEDICINE, 1995, 122 (07) :481-486
[7]   Chronic subclinical inflammation as part of the insulin resistance syndrome -: The Insulin Resistance Atherosclerosis Study (IRAS) [J].
Festa, A ;
D'Agostino, R ;
Howard, G ;
Mykkänen, L ;
Tracy, RP ;
Haffner, SM .
CIRCULATION, 2000, 102 (01) :42-47
[8]   BODY-FAT DISTRIBUTION AND 5-YEAR RISK OF DEATH IN OLDER WOMEN [J].
FOLSOM, AR ;
KAYE, SA ;
SELLERS, TA ;
HONG, CP ;
CERHAN, JR ;
POTTER, JD ;
PRINEAS, RJ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1993, 269 (04) :483-487
[9]   Prevalence of the metabolic syndrome among US adults - Findings from the Third National Health and Nutrition Examination Survey [J].
Ford, ES ;
Giles, WH ;
Dietz, WH .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 287 (03) :356-359
[10]  
Genuth S, 2003, DIABETES CARE, V26, P3160